LPA Receptors: Subtypes and Biological Actions

被引:665
作者
Choi, Ji Woong [1 ]
Herr, Deron R. [1 ]
Noguchi, Kyoko [1 ]
Yung, Yun C. [1 ]
Lee, Charig-Wook [1 ]
Mutoh, Tetsuji [1 ]
Lin, Mu-En [1 ]
Teo, Siew T. [1 ]
Park, Kristine E. [1 ]
Mosley, Alycia N. [1 ]
Chun, Jerold [1 ]
机构
[1] Scripps Res Inst, Dept Mol Biol, Helen L Dorris Inst Neurol & Psychiat Disorders, La Jolla, CA 92037 USA
基金
美国国家科学基金会;
关键词
lysophosphatidic acid; G protein-coupled receptor; autotaxin; brain; cancer; development; LYSOPHOSPHATIDIC ACID RECEPTOR; PROTEIN-COUPLED RECEPTOR; OVARIAN-CANCER CELLS; MOTILITY-STIMULATING PROTEIN; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; LYSOPHOSPHOLIPASE-D; NEUROPATHIC PAIN; PLATELET ACTIVATION; CARCINOMA CELLS;
D O I
10.1146/annurev.pharmtox.010909.105753
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling molecule by binding to and activating at least five known G protein-coupled receptors (GPCRs): LPA(1)-LPA(5). They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice. The biological roles of LPA are diverse and include developmental, physiological, and pathophysiological effects. I This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors. Studies using cloned receptors and genetic knockout mice have been instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ Systems Such,IS the nervous system. This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.
引用
收藏
页码:157 / 186
页数:30
相关论文
共 211 条
  • [1] A rat G protein-coupled receptor selectively expressed in myelin-forming cells
    Allard, J
    Barrón, S
    Diaz, J
    Lubetzki, C
    Zalc, B
    Schwartz, JC
    Sokoloff, P
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (03) : 1045 - 1053
  • [2] Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid
    An, SZ
    Bleu, T
    Hallmark, OG
    Goetzl, EJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (14) : 7906 - 7910
  • [3] Cell surface receptors in lysophospholipid signaling
    Anliker, B
    Chun, J
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (05) : 457 - 465
  • [4] Mechanisms of lysophosphatidic acid production
    Aoki, J
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (05) : 477 - 489
  • [5] Plasma lysophosphatidic acid concentration and ovarian cancer
    Baker, DL
    Morrison, P
    Miller, B
    Riely, CA
    Tolley, B
    Westermann, AM
    Bonfrer, JMG
    Bais, E
    Moolenaar, WH
    Tigyi, G
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (23): : 3081 - 3082
  • [6] Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry
    Baker, DL
    Desiderio, DM
    Miller, DD
    Tolley, B
    Tigyi, GJ
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 292 (02) : 287 - 295
  • [7] Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo
    Balazs, L
    Okolicany, J
    Ferrebee, M
    Tolley, B
    Tigyi, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (02) : R466 - R472
  • [8] Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid
    Bandoh, K
    Aoki, J
    Hosono, H
    Kobayashi, S
    Kobayashi, T
    Murakami-Murofushi, K
    Tsujimoto, M
    Arai, H
    Inoue, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (39) : 27776 - 27785
  • [9] Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species - Structure-activity relationship of cloned LPA receptors
    Bandoh, K
    Aoki, J
    Taira, A
    Tsujimoto, M
    Arai, H
    Inoue, K
    [J]. FEBS LETTERS, 2000, 478 (1-2) : 159 - 165
  • [10] Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific
    Baudhuin, LM
    Cristina, KL
    Lu, J
    Xu, Y
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (03) : 660 - 671